| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| IMRN | $2.13 | 3.398% | 9 | 9 | $12 | $1.90 | 12.1% |
Immuron Limited
62 Lygon Street
Level 3
Carlton, VIC 3053
Australia
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases.